Trial intelligence / Profile preview

Propofol vs Sevoflurane in Cardiac Surgery

NCT06729086Not yet recruiting

Sponsor
Saint Joseph's University
Start
Jan 2025
Primary completion
Mar 2025
Modality
Small Molecules
01

Overview

Randomised trial of sevoflurane in coronary artery disease (CAD) and heart valve disease (VHD) (2 arms), sponsored by Saint Joseph's University. Primary endpoint: Relationship between myocardial protection and type of anesthesia. Planned start Jan 2025; status: not yet recruiting.

02

Drugs

sevoflurane
03

Conditions

coronary artery disease (CAD)heart valve disease (VHD)

Beyond the preview

Go deeper on NCT06729086.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06729086.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call